Adefovir and Lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)692 A-692A
JournalHepatology
Volume4 suppl 1
Publication statusPublished - 2006

Cite this